Beranda › Leukemia Limfoblastik Akut › Washington › Spokane
Uji klinis Leukemia Limfoblastik Akut di Spokane, WA
3 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi sekitar Spokane (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Uji klinis Leukemia Limfoblastik Akut di kota lain
- Houston, TX28 studi
- New York City, NY24 studi
- Baldwin Park, CA21 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Philadelphia, PA16 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Durham, NC13 studi
Studi lain di Spokane
- Kanker Paru Non-Sel Kecil12 studi
- Kanker Payudara8 studi
- Kanker Ovarium8 studi
- Kanker Kolorektal8 studi
- Penyakit Parkinson7 studi
- Kanker Prostat6 studi
- Leukemia Limfositik Kronis6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker (semua jenis)6 studi
- Kanker Payudara Triple-Negatif5 studi
- Melanoma5 studi
- Degenerasi Makula5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.